MEDICILON

contact us jpkrencn

お知らせ

お知らせ

あなたはここにいる:ホーム > お知らせ

  • 08
    18

    2015

    DNA Vitamin E Complex Works as Potent Gene Silencer

    Gene silencing is an effective method for turning down or off the aberrant genetic message that leads toward disease phenotypes. Therapeutics that takes advantage of this technology are beginning to enter the market. However, opportunities still remain for improving the efficient delivery of nucleic acid drugs to the relevant diseased tissues.

  • 08
    18

    2015

    Engineering Therapeutic Proteins into Antibodies

    Scientists at the Scripps Research Institute (TSRI) have devised an improved method for building proteins into larger proteins such as antibodies.

  • 08
    17

    2015

    Roche to Acquire GeneWEAVE for Up to $425M

    Roche said it plans to acquire GeneWEAVE for up to $425 million, in a deal intended to strengthen its offerings in clinical microbiology diagnostics.

  • 08
    17

    2015

    DNA Repair Genes May Determine When Huntington Symptoms Begin

    A research team that searched the chromosomes of more than 4,000 Huntington's disease patients reports that they found that DNA repair genes may determine when the neurological symptoms begin. The scientists believe the results may provide a guide for discovering new treatments for Huntington's disease and a roadmap for studying other neurological disorders.

  • 08
    14

    2015

    Jackson Laboratory Launches Precision Genetics Center with $10M NIH Grant

    The Jackson Laboratory (JAX) will partner with several collaborating institutions to establish a new Center for Precision Genetics, to be launched through a five-year, $9,971,936 grant from the NIH.